TerrAscend: Analyst Consensus Estimates For Q3 2021

TerrAscend Corp (CSE: TER) announced that they will be reporting their third quarter financials before the markets open on November 16th.

Analysts have a consensus C$17.96 12-month price target on the company, via a total of 8 analysts, with 3 analysts having strong buy ratings, and the other 5 having buy ratings on the company. The street high comes from Stifel-GMP with an C$23 price target, and the lowest target comes from Needham & Company with a C$13.70 price target.

8 analysts have revenue estimates for the third quarter. The mean between all 8 is US$57.82 million; this number has been revised down from US$80.98 million at the start of May. The street high is US$62 million while the lowest sits at US$54.30 million.

7 analysts have estimates for what this quarter’s gross profit margin will be. They expect the profit margin to come in at 57.84%, with this number being lower than at the start of May. Street high is 60.70% estimate and the lowest sits at 52%.

Onto EBITDA estimates, there are currently 8 analysts who have third quarter EBITDA estimates. The mean is currently US$19.98 million, with this number has been revised downwards from US$34.01 million at the start of May. Street high sits at US$23.40 million EBITDA and the lowest being a US$15.90 million estimate.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver Is a Wild Animal, Gold Heads for $6,000 in 2026 | Craig Hemke

Is This the End of the Gold and Silver Rally? | Peter Grandich

Why Gold And Silver Stay High Even After Rate Cuts | Todd Bubba Horwitz

Recommended

TomaGold Confirms Presence Of Berrigan Deep Zone Following Geophysics

Antimony Resources Reports Massive Stibnite Mineralization Over 25 Metres At Marcus (West) Zone

Related News

Canaccord Lowers Cresco Labs’ Price Target To $9.50

On May 18th, Cresco Labs (CSE: CL) reported its first quarter financial results. The company...

Saturday, May 21, 2022, 03:02:00 PM

Gold Royalty: BMO Cuts Target After Recent Royalty Purchases

On September 1st, Gold Royalty Corp. (NYSE: GROY) announced that it has entered into an...

Sunday, September 11, 2022, 05:06:00 PM

Hycroft Mining: BMO Indicates Company Still Doesn’t Have Sufficient Capital For Mine Restart

On the evening of March 25, Hycroft Mining Holding Corporation (NASDAQ: HYMC) announced it had...

Thursday, March 31, 2022, 05:01:00 PM

Apple: Analysts Anticipate Q4 Revenues Of $84.85 Billion

Apple (NASDAQ: AAPL) will be reporting its fourth quarter financial results on October 27th after...

Tuesday, October 26, 2021, 05:25:00 PM

Small Pharma: Canaccord Initiates Coverage With $1.00 Price Target

Canaccord Genuity recently initiated coverage on Small Pharma Inc (TSXV: DMT), a company that is...

Sunday, June 13, 2021, 01:08:00 PM